HUP0100095A3
(en )
2001-12-28
A double capsule for the administration of active principles in multiple therapies
ZA9710994B
(en )
1998-07-10
Pharmaceutical formulations for sustained drug delivery
HUP0100900A3
(en )
2002-08-28
Pharmaceutically active morpholinol and medicaments containing them
AU7375598A
(en )
1998-11-27
Stable oral pharmaceutical dosage forms
PL328399A1
(en )
1999-01-18
Drug administration aid
PL342515A1
(en )
2001-06-18
Drug administering device
HK1079718A1
(en )
2006-04-13
Intracardiac drug delivery
IL149224A0
(en )
2002-11-10
Hydrogen-driven drug dosage form
PT1200118E
(en )
2008-03-18
A pharmaceutical formulation comprising megalatran and its prodrug
ZA200308221B
(en )
2004-09-29
Pharmaceutical compositions for oral and topical administration.
EP1013269A4
(en )
2002-02-20
Improvement in medicament administration system
GB9918885D0
(en )
1999-10-13
Pharmaceutical formulations in hydroxypropymethycellulose capsules
GB9714750D0
(en )
1997-09-17
Drug delivery device
AU3055099A
(en )
1999-12-06
A pharmaceutical formulation for nasal administration
ZA9960B
(en )
1999-08-18
A stable isotonic pharmaceutical formulation for storage and therapeutic administration.
HUP0105097A2
(en )
2002-06-29
Pharmaceutical mixtures comprising a combination of a profen and other active compounds
EP1234834A4
(en )
2003-01-29
1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
PL325509A1
(en )
1998-09-28
Therapeutic agent for oral administration
AU3860797A
(en )
1999-02-10
Pharmaceutical formulations for oral administration
EP0995758A4
(en )
2002-08-14
Physiologically active polyoxypeptin and deoxypolyoxypeptin and anticancer drugs containing the same
ZA99349B
(en )
1999-09-29
A pharmaceutical formulation.
GB9620031D0
(en )
1996-11-13
Drug administration device
CZ2001512A3
(en )
2001-07-11
Transdermally administered aspirin
IL120172A0
(en )
1997-06-10
Pharmaceutical dosage form
GB9712357D0
(en )
1997-08-13
Pharmaceutical dosage form